Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose Vitamin C and TCM for COVID-19
NCT04664010Completed
- Sponsor
- Xi'an International Medical Center Hospital
- Start
- Feb 2020
- Primary completion
- Sep 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of ascorbic acid and buzhong yiqi in coronavirus disease 2019 (COVID-19) (6 arms), sponsored by Xi'an International Medical Center Hospital. Primary endpoint: Recovery time up to 6 months. Started Feb 2020; status: completed.
02
Drugs
ascorbic acidbuzhong yiqi
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04664010.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04664010.